KFx Medical Corporation
Receives 510k Clearance for Knotless Tissue Fixation
SAN DIEGO, CA – AUGUST
10, 2006
KFx Medical Corporation, a developer of
minimally invasive percutaneous repair systems for rotator
cuff repair announced today that it has received FDA clearance
to market its SutureCross™ Knotless Anatomic Fixation
System.
Dr. Joseph C. Tauro, one of the pioneers
in arthroscopic cuff repair in private practice at Ocean County
Sports Medicine in Toms River, NJ and Assistant Clinical Professor
of Orthopedic Surgery at New Jersey Medical School and Chairman
of the KFx Scientific Advisory Board said, “This is the
most exciting new development for rotator cuff repair in a
decade. I’m proud to have been part of the development
process.”
“KFx’s unique double row SutureCross™ system
has been in development for a number of years,” said
Tate Scott, President and CEO. “We will first use this
system at select Centers of Excellence around the country prior
to our full market launch.”
Over four million people seek medical advice
for shoulder pain every year; torn rotator cuffs alone account
for more than 500,000 surgeries annually and have traditionally
required many weeks of rehabilitation. Traditional minimally
invasive techniques, although promising - patients typically
experience less pain and regain full range of motion more quickly
- require surgeons to have advanced arthroscopic skills. In
contrast, KFx provides simple minimally invasive products for
surgeons that enable a more anatomical repair for the patient.
About KFx Medical
Corporation
Headquartered in Carlsbad, Calif., KFx Medical Corporation was founded in 2003
to develop clinically relevant solutions to rotator cuff repair. The company
is privately held — Investors include Charter Life Sciences, Arboretum
Ventures, Montreux Equity Partners, and MB Ventures.
CONTACT:
Tate Scott
President & CEO
KFx Medical Corporation
5145 Avenida Encinas, Ste C
Carlsbad, CA 92008 |
